Moreover, ALT and GGT activities were significantly higher in COVID-19 patients than in the control group (p = 0.02 and p = 0.003, respectively), while there were no significant differences in AST activity or bilirubin level (p = 0.38 and p = 0.25, respectively). The gene discussed is GPT; the disease is COVID-19.